Document Detail


Current therapeutic principles as well as new therapeutic aspects of idiopathic hypertrophic subaortic stenosis. II. Chemotherapeutic and direct surgical therapy
MedLine Citation:
PMID:  6105746     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The severity of the functional obstruction of the outflow tract of an idiopathic hypertrophic subaortic stenosis is essentially determined by the contractility of the myocardium, the left-ventricular volume and the peripheral vascular resistance. Though in the acute experiment a clear reduction of the degree of stenosis by beta-receptor-blockers may be proved the long-term results of such a therapy are unsatisfactory, particularly in patients with obstruction in rest. The use of calcium antagonists seems to promise more favourable results. The progression of the disease is, however, scarcely influencible by pharmacological measures alone. Nitrobodies are not suitable for treatment and glycosides should be used only within a manifest insufficiency of the left heart. An effective reduction or removal of the ventriculo-ventricular pressure gradient as well as a decrease of the left-ventricular telediastolic pressure may be achieved on operative way. There is an indication to this, when the complaints increase despite medicamentous therapy. At present the transaortic myotomy under use of the heart-lung-machine is regarded as most favourable method. A simultaneous or only substitute of the mitral valve should be restricted only to those cases which, apart from the functional, still show an organically conditioned insufficiency of the mitral valve. The early and late results of the palliative surgical interventions are very favourable in experienced centres. However, secure long-term prognoses may not yet be derived from this.
Authors:
W Hutschenreiter; H J Duck; H Trenckmann; M Herbst; K Günther
Publication Detail:
Type:  English Abstract; Journal Article; Review    
Journal Detail:
Title:  Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete     Volume:  35     ISSN:  0044-2542     ISO Abbreviation:  Z Gesamte Inn Med     Publication Date:  1980 Mar 
Date Detail:
Created Date:  1980-10-21     Completed Date:  1980-10-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  21730470R     Medline TA:  Z Gesamte Inn Med     Country:  GERMANY, EAST    
Other Details:
Languages:  ger     Pagination:  197-206     Citation Subset:  IM    
Vernacular Title:
Gegenwärtige Behandlungsprinzipien sowie neue therapeutische Aspekte der idiopathischen hypertrophischen Subaortenstenose (IHSS). II. Mitteilung: Medikamentöse und direkte chirurgische Therapie.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use*
Anti-Arrhythmia Agents / therapeutic use
Aortic Stenosis, Subvalvular / surgery,  therapy*
Calcium / antagonists & inhibitors
Cardiac Glycosides / therapeutic use
Cardiac Surgical Procedures / methods
Cardiomyopathy, Hypertrophic / therapy*
Heart Function Tests
Heart Valve Prosthesis
Humans
Isoproterenol / therapeutic use
Propranolol / therapeutic use
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Anti-Arrhythmia Agents; 0/Cardiac Glycosides; 525-66-6/Propranolol; 7440-70-2/Calcium; 7683-59-2/Isoproterenol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pseudovaginal perineoscrotal hypospadias: genetic heterogeneity.
Next Document:  Therapeutic principles of drug-induced cardiac debit with vasodilators